Orbis Biosciences Inc. has just signed an exclusive licensing agreement with the company behind Mucinex, Calgon, Woolite and other well-known brands.

The Lenexa-based Orbis specializes in pharmaceutical manufacturing. Under its new, global license agreement, Orbis will work with Reckitt Benckiser to develop new technologies for consumer, over-the-counter health care.

“We are proud to be partnering with one of the largest consumer products companies in the world to create differentiated products for their portfolio,” said Maria Flynn, CEO and president of Orbis Biosciences.

“The ability to add novel products to their extensive offering will provide patients the choice and flexibility they need to ease administration challenges.”

The deal’s financial terms weren’t disclosed.

Orbis Biosciences has developed “Precision Particle Fabrication” technology that allows medicine, whether it’s injected or taken orally, to be released into the body over time instead of all at once.

“We are very excited to partner with the Orbis Biosciences talented team to strengthen further our innovation pipeline in strategic areas of our leading consumer health relief portfolio,” said Laurent Faracci, executive vice president of category development for RB Health.

“At RB, we believe that vibrant partnerships are critical in delivering RB purpose of innovative solutions for Healthier Lives and Happier Homes.”

Orbis Biosciences is a 2012 winner of the 25 Under 25® Award from Thinking Bigger Business Media.